Peptide Comparison
Matrixyl vs Pal-AHK
Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.
Data-derived verdict
Matrixyl and Pal-AHK share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Matrixyl has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Matrixyl's evidence base is currently denser.
Evidence at a glance
FDA-approved Phase 3 Phase 2 / approved abroad Anecdotal + animal Preclinical / flagged
Shared safety considerations
Both compounds share these reported concerns: minimal. Open each peptide page for the full risk paragraph and source citations.
Side-by-side
| Matrixyl | Pal-AHK | |
|---|---|---|
| Class | Cosmetic signal peptide; collagen stimulator | Cosmetic lipopeptide (hair) |
| Drug class | Dermatologic | Dermatologic |
| Mechanism | Mimics procollagen I fragment; signals fibroblasts to produce collagen, elastin, GAGs | Palmitoyl-modified AHK for enhanced skin/scalp penetration; angiogenic signaling |
| Route | Topical | Topical |
| Half-life | Topical | Topical |
| Dosage (research) | Topical 3-10% | Topical 0.1-1% |
| Evidence tier | Cosmetic Clinical Studies | Cosmetic Clinical Studies |
| Research depth | 32 indexed | 2 indexed |
| Availability | Cosmetic | Cosmetic |
| Reported risks | Minimal (topical) | Minimal |
Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.
Frequently asked questions
Should I pick Matrixyl or Pal-AHK?
Matrixyl and Pal-AHK share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Matrixyl has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Matrixyl's evidence base is currently denser.
What is the difference between Matrixyl and Pal-AHK?
Matrixyl is classed as Cosmetic signal peptide; collagen stimulator; Pal-AHK is classed as Cosmetic lipopeptide (hair). Reported mechanism: Matrixyl, Mimics procollagen I fragment; signals fibroblasts to produce collagen, elastin, GAGs; Pal-AHK, Palmitoyl-modified AHK for enhanced skin/scalp penetration; angiogenic signaling. Reported half-life: Matrixyl, Topical; Pal-AHK, Topical. Routes in published studies: Matrixyl, Topical; Pal-AHK, Topical.
Which has stronger evidence, Matrixyl or Pal-AHK?
Matrixyl and Pal-AHK sit on the same rung of PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Matrixyl is graded Cosmetic Clinical Studies, with 6 cited sources on its reference page and 32 indexed studies. Pal-AHK is graded Cosmetic Clinical Studies, with 2 cited sources on its reference page and 2 indexed studies.
Which is more accessible, Matrixyl or Pal-AHK?
Neither Matrixyl nor Pal-AHK is an FDA-approved drug. Catalog status: Matrixyl, Cosmetic; Pal-AHK, Cosmetic.
Are Matrixyl and Pal-AHK ever combined?
Matrixyl and Pal-AHK appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.
Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.
Loading interactive view…